Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial

Blackwood, R., Wolstenholme, A., Kimergård, A., Fincham-Campbell, S., Khadjesari, Z. ORCID: https://orcid.org/0000-0002-2958-9555, Coulton, S., Byford, S., Deluca, P., Jennings, S. ORCID: https://orcid.org/0000-0002-2390-7225, Currell, E., Dunne, J., O'Toole, J., Winnington, J., Finch, E. and Drummond, C. (2020) Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial. BMC Public Health, 20 (1). ISSN 1471-2458

Preview

PDF (Published_Version) - Published Version Available under License Creative Commons Attribution. Download (748kB) | Preview

Abstract

BACKGROUND: Alcohol-related hospital admissions have doubled in the last ten years to > 1.2 m per year in England. High-need, high-cost (HNHC) alcohol-related frequent attenders (ARFA) are a relatively small subgroup of patients, having multiple admissions or attendances from alcohol during a short time period. This trial aims to test the effectiveness of an assertive outreach treatment (AOT) approach in improving clinical outcomes for ARFA, and reducing resource use in the acute setting. METHODS: One hundred and sixty ARFA patients will be recruited and following baseline assessment, randomly assigned to AOT plus care as usual (CAU) or CAU alone in equal numbers. Baseline assessment includes alcohol consumption and related problems, physical and mental health comorbidity and health and social care service use in the previous 6 months using standard validated tools, plus a measure of resource use. Follow-up assessments at 6 and 12 months after randomization includes the same tools as baseline plus standard measure of patient satisfaction. Outcomes for CAU + AOT and CAU at 6 and 12 months will be compared, controlling for pre-specified baseline measures. Primary outcome will be percentage of days abstinent at 12 months. Secondary outcomes include emergency department (ED) attendance, number and length of hospital admissions, alcohol consumption, alcohol-related problems, other health service use, mental and physical comorbidity 6 and 12 months post intervention. Health economic analysis will estimate the economic impact of AOT from health, social care and societal perspectives and explore cost-effectiveness in terms of quality adjusted life years and alcohol consumption at 12-month follow-up. DISCUSSION: AOT models piloted with alcohol dependent patients have demonstrated significant reductions in alcohol consumption and use of unplanned National Health Service (NHS) care, with increased engagement with alcohol treatment services, compared with patients receiving CAU. While AOT interventions are costlier per case than current standard care in the UK, the rationale for targeting HNHC ARFAs is because of their disproportionate contribution to overall alcohol burden on the NHS. No previous studies have evaluated the clinical and cost-effectiveness of AOT for HNHC ARFAs: this randomized controlled trial (RCT) targeting ARFAs across five South London NHS Trusts is the first. TRIAL REGISTRATION: International standard randomized controlled trial number (ISRCTN) registry: ISRCTN67000214, retrospectively registered 26/11/2016.

Item Type:	Article
Uncontrolled Keywords:	sdg 3 - good health and well-being,sdg 12 - responsible consumption and production ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Depositing User:	LivePure Connector
Date Deposited:	26 Mar 2020 01:30
Last Modified:	22 Oct 2022 05:58
URI:	https://ueaeprints.uea.ac.uk/id/eprint/74617
DOI:	10.1186/s12889-020-8437-y

Downloads

Actions (login required)

View Item